The PLs lab and others have previously shown that aged, learning-impaired animals have deficits in both the early and late phases of LTP. The focus of the current proposal will be on attempts to identify the cellular and molecular bases of these deficits. In addition, in collaborations with other members of this program project, the PL will also examine nutritional and growth-factor-based interventions for their ability to ameliorate age-related molecular, cellular and behavioral deficits.
Aims 1 and 2 will focus on early phase LTP that is usually defined as the first 30-120 minutes following LTP induction. In the previous funding period, the PL demonstrated that age-related deficits in NMDAR function might play a role in deficits in the early phase of LTP and behavior.
In aim 1, he will use correlational analyses to test this hypothesis.
In aim 2, he will attempt to identify the mechanism of these age-related deficits in NMDAR function. This will include analyses of NMDAR gene transcription, mRNA and subunit protein turnover. In the previous funding period, the PL also demonstrated that there was a relatively selective, PKA-dependent increase in the transcription and synthesis of the k/AMPAR that may underlie the potentiation seen in the late phase of LTP.
In Aims 3 and 4, he will attempt to determine whether deficits in either the PKA-regulated k/AMPA gene expression or the synaptic targeting of the newly synthesized k/AMPAR underlie age-related deficits in late phase LTP. Lastly, in Aim 5 he will examine the ability of nutritional and growth-factor- based interventions to prevent or ameliorate the age-related deficits.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG004418-19
Application #
6611065
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2002-07-15
Project End
2003-06-30
Budget Start
Budget End
Support Year
19
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Bickford, Paula C; Flowers, Antwoine; Grimmig, Bethany (2017) Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases. Exp Gerontol 94:4-8
Grimmig, Bethany; Kim, Seol-Hee; Nash, Kevin et al. (2017) Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience 39:19-32
Tajiri, Naoki; Acosta, Sandra A; Shahaduzzaman, Md et al. (2014) Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J Neurosci 34:313-26
Lee, Daniel C; Ruiz, Claudia R; Lebson, Lori et al. (2013) Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiol Aging 34:1610-20
Lee, D C; Rizer, J; Hunt, J B et al. (2013) Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology. Neuropathol Appl Neurobiol 39:69-85
Ross, Jaime M; Stewart, James B; Hagström, Erik et al. (2013) Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature 501:412-5
Shahaduzzaman, Md; Golden, Jason E; Green, Suzanne et al. (2013) A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus. Age (Dordr) 35:2071-87
Olson, Linus; Faulkner, Stuart; Lundströmer, Karin et al. (2013) Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain. Transl Stroke Res 4:248-57
Freeman, Linnea R; Granholm, Ann-Charlotte E (2012) Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. J Cereb Blood Flow Metab 32:643-53
Morganti, Josh M; Nash, Kevin R; Grimmig, Bethany A et al. (2012) The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J Neurosci 32:14592-601

Showing the most recent 10 out of 317 publications